Mirae Asset Global Investments
DNA icon

Mirae Asset Global Investments’s Ginkgo Bioworks DNA Stock Holding History

Mirae Asset Global Investments’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,264
Closed -$596K – 2607
2022
Q2 		$596K Buy
6,264
+2,192
+54% +$267K ﹤0.01% 1666
2022
Q1 		$657K Buy
4,072
+1,999
+96% +$389K ﹤0.01% 1408
2021
Q4 		$689K Buy
+2,073
New +$985K ﹤0.01% 1390

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mirae Asset Global Investments's DNA Position: Q3 2022 in Review

Mirae Asset Global Investments sold out of Ginkgo Bioworks (DNA) in Q3 2022, closing a stake of 6,264 shares — an estimated $596K sold.

Mirae Asset Global Investments first reported a position in DNA in Q4 2021 and held it in 3 quarters. The position peaked at $689K in Q4 2021. 278 funds tracked by Wall St. Rank hold DNA as of Q3 2022.

  • Mirae Asset Global Investments reported no remaining Ginkgo Bioworks position as of Q3 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 6,264 Ginkgo Bioworks shares in Q3 2022, an estimated $596K.
  • Mirae Asset Global Investments first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 3 quarters.
  • Mirae Asset Global Investments's Ginkgo Bioworks position peaked at $689K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2022.

Based on Mirae Asset Global Investments's 13F filing for Q3 2022, filed 10 Nov 2022.